Department of Gastroenterology and Hepatology, Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, West China Hospital, Sichuan University, Chengdu, China.
Eur J Gastroenterol Hepatol. 2022 Oct 1;34(10):1074-1080. doi: 10.1097/MEG.0000000000002427. Epub 2022 Aug 24.
It is important and challenging to evaluate the survival of cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt (TIPS). We aimed to validate the Freiburg index of post-TIPS survival (FIPS) score and classic scores for predicting mortality in Chinese patients after TIPS creation.
A total of 709 consecutive patients with cirrhosis from December 2011 to July 2018 who underwent TIPS placement were retrospectively reviewed. The prognostic value of the FIPS score, the model for end-stage liver disease (MELD) score, Child-Pugh score and Chronic Liver Failure Consortium Acute Decompensation score was validated with the receiver operating characteristic (ROC) curve and DeLong et al. test.
The MELD-Na score was superior to the FIPS score in predicting 1-month mortality [AUROC, 0.727 (0.692-0.759) vs. 0.588 (0.551-0.625); P = 0.048]. The MELD and MELD-Na scores were significant superior to the FIPS score in predicting 3-month mortality [AUROC, 0.730 (0.696-0.762) vs. 0.598 (0.561-0.634); P = 0.044 and 0.740 (0.706-0.772) vs. 0.598 (0.561-0.634); P = 0.028]. Subgroup analyses revealed that Child-Pugh score was better than FIPS score in predicting 3-month mortality [AUROC, 0.797 (0.745-0.843) vs. 0.578 (0.517-0.637); P = 0.049] in nonviral cirrhosis group.
Classic scores still had good risk stratification and predictive ability of post-TIPS mortality. The FIPS score was not superior to the classic scores in the current Chinese cohort. The MELD and MELD-Na scores were significantly superior to the FIPS score in predicting 3-month mortality.
评估接受经颈静脉肝内门体分流术(TIPS)的肝硬化患者的生存情况非常重要且具有挑战性。本研究旨在验证弗赖堡 TIPS 术后生存指数(FIPS)评分和经典评分在预测中国 TIPS 术后患者死亡率方面的价值。
回顾性分析了 2011 年 12 月至 2018 年 7 月期间 709 例连续接受 TIPS 治疗的肝硬化患者的临床资料。采用受试者工作特征(ROC)曲线和 DeLong 检验评估 FIPS 评分、终末期肝病模型(MELD)评分、Child-Pugh 评分和慢性肝脏衰竭联盟急性失代偿评分的预测价值。
MELD-Na 评分在预测 1 个月死亡率方面优于 FIPS 评分[AUROC:0.727(0.692-0.759)比 0.588(0.551-0.625);P=0.048]。MELD 和 MELD-Na 评分在预测 3 个月死亡率方面均显著优于 FIPS 评分[AUROC:0.730(0.696-0.762)比 0.598(0.561-0.634);P=0.044 和 0.740(0.706-0.772)比 0.598(0.561-0.634);P=0.028]。亚组分析显示,在非病毒性肝硬化组中,Child-Pugh 评分在预测 3 个月死亡率方面优于 FIPS 评分[AUROC:0.797(0.745-0.843)比 0.578(0.517-0.637);P=0.049]。
经典评分对 TIPS 术后死亡率仍具有良好的风险分层和预测能力。在当前中国人群中,FIPS 评分并不优于经典评分。MELD 和 MELD-Na 评分在预测 3 个月死亡率方面明显优于 FIPS 评分。